TMCnet News
Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service(PR Web Via Acquire Media NewsEdge) Norristown, PA (PRWEB) October 20, 2014 Myoderm announced today the hiring of Matthew Voicheck as Assistant Director of their CentralSource service. Matthew will play an integral role in managing the innovative turnkey drug sourcing, distribution, and management service for international clinical trials. Matthew brings over 12 years of industry experience, in both business development and management. He joins Myoderm at the peak of their international success to help clients manage their clinical trials more effectively and efficiently through the implementation of the innovative, streamlined sourcing solution. Matthew comments "I am excited to start a new challenge with Myoderm and look forward to working with the team to further develop their already extensive sourcing services, as well as their global client and partner network. I am fortunate to be joining such a respected company that prides itself on top quality service." Michael Cohen, Managing Director of Myoderm remarks, "Our new innovations and the increasing demand from our customers led us to look for an addition to our team who fits in with our mission to deliver innovative solutions and exceptional service. It's very fortunate that we were able to find someone of Matthew's caliber to fulfill the role. We view his appointment as a sign of our commitment to being the leading company in our industry, and our commitment to providing the highest quality sourcing solutions for our clients." About Myoderm With headquarters in the US and UK, Myoderm is a global leader in sourcing, distribution, and management of drugs and supplies for clinical trials, including biosimilar research. For over 25 years, they have helped clients around the globe manage their sourcing needs, supplying over 3,000 sites worldwide. Their deep expertise, innovative sourcing solutions, and obsession with exceeding customers' expectations make them the choice of over 150 companies worldwide. Read the full story at http://www.prweb.com/releases/2014/10/prweb12259060.htm (c) 2014 PRWEB.COM Newswire |